Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • yassen_gregorivich yassen_gregorivich Nov 18, 2013 4:43 PM Flag

    Only known adverse event was a patient with known coronary disease

    Juxtapid isn't intended to treat coronary heart failure, and while it was an unfortunate event, they at least let the 58-year old patient in the study anyway (as they should IMHO, they should never stop someone from at least getting some relief even if something else (another disease) intervenes and takes over.

 
AEGR
17.61-0.15(-0.84%)3:22 PMEDT